Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Cash & Current Investments (2014 - 2026)

Ocugen's (OCGN) quarterly Cash & Current Investments came in at $37.8 million in Q1 2025, up 43.32% YoY from $26.4 million in Q1 2024, and up 140.81% on a QoQ basis from $15.7 million in Q2 2024.

Analysis

Ocugen (OCGN) Cash & Current Investments (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 12 years of Cash & Current Investments data on file, last reported at $37.8 million in Q1 2025.

  • Quarterly Cash & Current Investments rose 43.32% year-over-year to $37.8 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $37.8 million (up 43.32% YoY) and the FY2023 annual result came in at $39.5 million, down 56.6% from the prior year.
  • Cash & Current Investments rose to $37.8 million in Q1 2025, from $15.7 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $129.8 million in Q1 2022 to a low of $15.7 million in Q2 2024.
  • A 5-year average of $75.7 million and a median of $76.7 million in 2023 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 1459.04% — and 2024, when it tumbled 77.76%.
  • Tracing OCGN's Cash & Current Investments over 5 years: stood at $95.0 million in 2021, then dropped by 4.24% to $90.9 million in 2022, then slumped by 56.6% to $39.5 million in 2023, then plunged by 60.22% to $15.7 million in 2024, then surged by 140.81% to $37.8 million in 2025.
  • The last three Cash & Current Investments figures came in at $37.8 million (Q1 2025), $15.7 million (Q2 2024), and $26.4 million (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Ocugen 458.91 Mn 358.81 Mn - 100.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.10 Mn
Dec 31, 2025 18.57 Mn
Jun 30, 2025 27.01 Mn
Mar 31, 2025 37.80 Mn
Jun 30, 2024 15.70 Mn
Mar 31, 2024 26.40 Mn
Dec 31, 2023 39.46 Mn
Sep 30, 2023 53.48 Mn
Jun 30, 2023 70.58 Mn
Mar 31, 2023 76.72 Mn
Dec 31, 2022 90.93 Mn
Sep 30, 2022 101.60 Mn
Jun 30, 2022 115.01 Mn
Mar 31, 2022 129.77 Mn
Dec 31, 2021 94.96 Mn
Sep 30, 2021 112.34 Mn
Jun 30, 2021 120.63 Mn
Mar 31, 2021 49.78 Mn
Dec 31, 2020 24.04 Mn
Sep 30, 2020 19.11 Mn